Ryohkan Funakoshi

6PUBLICATIONS
15CO-AUTHORS
Clinical pharmacy and pharmacy practiceRecommender systemsPharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 07, 2025
Effectiveness of Outpatient Pharmaceutical Clinics in the Overseeing of Self-Injectable Biologic Prescriptions for Inflammatory Immune Diseases and the Cost-Effectiveness of Pharmacological Management.

Hiroki Oba, Ikkou Hirata, Masaki Inoue

|Sep 27, 2025
Changes in the trend and quality of adverse drug reaction reports in the Japanese Adverse Drug Event Report database and the impact of COVID-19-related reports.

Masami Tsuchiya, Takamasa Sakai, Naoto Okada

|Sep 20, 2025
Comparative analysis of the characteristics and trends of adverse drug reaction reports from patients in Japan and the Japanese Adverse Drug Event Report database.

Masami Tsuchiya, Ryohkan Funakoshi, Koichi Masuyama

|Jul 15, 2024
External Validation and Update of the Risk Prediction Model for Denosumab-Induced Hypocalcemia Developed From a Hospital-Based Administrative Database.

Keisuke Ikegami, Shungo Imai, Osamu Yasumuro

|Apr 06, 2022
Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D3 )/Calcium Supplement.

Keisuke Ikegami, Masayuki Hashiguchi, Hayato Kizaki

|Apr 01, 2022
Characteristics of hospitals that report adverse drug reactions: Results of a nationwide survey in Japan.

Masami Tsuchiya, Daisuke Kikuchi, Shiro Hatakeyama

Pageof 1

Frequent Collaborators

4 joint publications

Masami Tsuchiya

4 joint publications

Satoko Hori

3 joint publications

Taku Obara

2 joint publications

Keisuke Ikegami